Stable disease after high dose interleukin-2 (HD IL-2) immunotherapy: observations on long term survival and clinical benefit of additional HD IL-2. (6th November 2014) - Kaufman, Howard L; Aung, Sandra; Morse, Michael; Wong, Michael; Lowder, James; Daniels, Gregory; McDermott, David